Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1932 1
1935 1
1942 1
1946 1
1949 1
1952 1
1953 1
1956 1
1957 2
1958 2
1962 3
1963 2
1964 3
1965 4
1966 1
1967 1
1968 1
1969 3
1970 2
1972 1
1974 1
1975 5
1976 3
1977 1
1978 5
1980 3
1981 10
1982 4
1983 1
1984 3
1985 3
1986 5
1987 2
1988 2
1989 4
1990 3
1991 2
1992 2
1993 1
1994 3
1995 4
1996 2
1998 3
1999 1
2000 1
2001 1
2004 3
2005 2
2006 3
2007 2
2008 2
2009 7
2010 9
2011 6
2012 3
2013 5
2014 9
2015 12
2016 11
2017 19
2018 16
2019 11
2020 22
2021 32
2022 27
2023 36
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Results by year

Filters applied: . Clear all
Page 1
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Abdallah CG, et al. Among authors: sherif ma. Neuropsychopharmacology. 2022 Jul;47(8):1574-1581. doi: 10.1038/s41386-022-01266-9. Epub 2022 Jan 19. Neuropsychopharmacology. 2022. PMID: 35046508 Free PMC article. Clinical Trial.
Cannabinoids and Psychosis.
D'Souza DC, Radhakrishnan R, Sherif M, Cortes-Briones J, Cahill J, Gupta S, Skosnik PD, Ranganathan M. D'Souza DC, et al. Among authors: sherif m. Curr Pharm Des. 2016;22(42):6380-6391. doi: 10.2174/1381612822666160826105628. Curr Pharm Des. 2016. PMID: 27568729 Review.
The Psychiatric Consequences of Cannabinoids.
De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC. De Aquino JP, et al. Among authors: sherif m. Clin Ther. 2018 Sep;40(9):1448-1456. doi: 10.1016/j.clinthera.2018.03.013. Epub 2018 Apr 17. Clin Ther. 2018. PMID: 29678279 Review.
Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM, Englund A, Abi-Dargham A, Lewis DA, Di Forti M, Davies C, Sherif M, McGuire P, D'Souza DC. Murray RM, et al. Among authors: sherif m. Neuropharmacology. 2017 Sep 15;124:89-104. doi: 10.1016/j.neuropharm.2017.06.018. Epub 2017 Jun 17. Neuropharmacology. 2017. PMID: 28634109 Review.
MitraClip step by step; how to simplify the procedure.
Sherif MA, Paranskaya L, Yuecel S, Kische S, Thiele O, D'Ancona G, Neuhausen-Abramkina A, Ortak J, Ince H, Öner A. Sherif MA, et al. Neth Heart J. 2017 Feb;25(2):125-130. doi: 10.1007/s12471-016-0930-7. Neth Heart J. 2017. PMID: 27933588 Free PMC article. Review.
Human Laboratory Studies on Cannabinoids and Psychosis.
Sherif M, Radhakrishnan R, D'Souza DC, Ranganathan M. Sherif M, et al. Biol Psychiatry. 2016 Apr 1;79(7):526-38. doi: 10.1016/j.biopsych.2016.01.011. Epub 2016 Feb 2. Biol Psychiatry. 2016. PMID: 26970363 Review.
333 results